MeiraGTx Announces Proposed Public Offering of Ordinary Shares
August 07, 2019 16:12 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has...
MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update
August 07, 2019 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results...
MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 14, 2019 08:00 ET
|
MeiraGTx
• Positive 6-month results from Phase 1/2 clinical trial of AAV-RPE65 • Enrollment completed in the Phase 1/2 clinical trial investigating AAV-CNGB3 gene therapy for the treatment of achromatopsia ...
MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
May 14, 2019 07:30 ET
|
MeiraGTx
AAV-RPE65 met the primary endpoint of safety and tolerability Statistically significant improvement demonstrated in vision-guided mobility and visual function in treated eyes compared to untreated...
MeiraGTx Appoints Nicole Seligman to Board of Directors
May 10, 2019 08:30 ET
|
MeiraGTx
LONDON and NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of...
MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference
May 06, 2019 16:30 ET
|
MeiraGTx
LONDON and NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,...
MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019
April 25, 2019 16:30 ET
|
MeiraGTx
LONDON and NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced a pre-clinical poster on...
MeiraGTx Reports Full Year 2018 Financial Results
March 26, 2019 16:05 ET
|
MeiraGTx
LONDON and NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results...
MeiraGTx to Present at the Barclays Global Healthcare Conference
March 06, 2019 16:30 ET
|
MeiraGTx
LONDON and NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
February 27, 2019 08:15 ET
|
MeiraGTx
LONDON and NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell...